Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Lung Allograft Dysfunction: full-pipeline trial registry
1 of 2 indexed Chronic Lung Allograft Dysfunction trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Chronic Lung Allograft Dysfunction: 2 US clinical trials tracked, 1 recruiting.
Chronic Lung Allograft Dysfunction is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Zambon SpA, running 1 of these trials.
Enrollment posture brief
Registry condition chronic-lung-allograft-dysfunction
OPEN 1 | RECR 50% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Chronic Lung Allograft Dysfunction lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Lung Allograft Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Lung Allograft Dysfunction is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Steven Hays, MD
NCT06018766
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Zambon SpA
NCT03656926
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Lung Allograft Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Lung Allograft Dysfunction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Lung Allograft Dysfunction page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Chronic Lung Allograft Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Zambon SpA sponsors the most Chronic Lung Allograft Dysfunction trials on record, review their full trial history before evaluating a specific study. See Zambon SpA's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Lung Allograft Dysfunction condition card totals 2 registered trials; most-linked intervention Liposomal Cyclosporine A; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.